LIVE MARKET TRACKER :   BSE SENSEX   33053.04      |    NSE NIFTY 10192.95    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  SML Isuzu shines on reporting 30.3% jump in July sales

SML Isuzu shines on reporting 30.3% jump in July sales (01-Aug-2016)

SML Isuzu is currently trading at Rs 1340.00, up by 80.40 points or 6.38% from its previous closing of Rs 1259.60 on the BSE.

The scrip opened at Rs. 1271.00 and has touched a high and low of Rs 1349.95 and Rs 1271.00 respectively. So far 66063 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1599.90 on 04-Aug-2015 and a 52 week low of Rs. 645.50 on 29-Feb-2016.

Last one week high and low of the scrip stood at Rs 1,349.95 and Rs 1169.55 respectively. The current market cap of the company is Rs 1924.73 crore.

The promoters holding in the company stood at 43.96%, while Institutions and Non-Institutions held 7.35% and 48.69% respectively.

SML Isuzu has reported 30.3% rise in July sales. The company has sold 1,368 vehicles during July 2016 against 1,050 vehicles sold in July 2015. The cumulative sales for April-June 2016 stood at 4,893 vehicles, a rise of 28.4% as compared to 3,810 vehicles sold in April-June 2015.

SML Isuzu manufactures a range of vehicles such as trucks, buses and ambulances. The company has launched products like 4WD, Samrat, Sartaj, Dual Cab, Supreme-8 tonner, Truck- Super 12, Super ALFD and many more.


Top News Today
Talwalkars commences construction of first leisure club in Pune
(13-Dec-2017)

Talwalkars commences construction of first leisure club in PuneTalwalkars Better Value Fitness has commenced the construction of its first leisure club in Wakad, Pune. Post the compliance of various statutory procedures, the club project has received necessary sanctions......click on news to read complete article.

NIIT features in '2017 Top 20 IT Training Company' list
(13-Dec-2017)

NIIT features in NIIT has been featured by Training Industry among 2017 Top 20 IT Training Company for the eighth consecutive year. Training Industry is one of the most trusted sources of information on the business of......click on news to read complete article.

Orchid Pharma receives ANDA approval for Aripiprazole Orally-Disintegrating Tablets
(13-Dec-2017)

Orchid Pharma receives ANDA approval for Aripiprazole Orally-Disintegrating TabletsOrchid Pharma has received ANDA approval from USFDA for Aripiprazole Orally-Disintegrating Tablets USP, 10 mg and 15 mg. Aripiprazole Orally-Disintegrating Tablets are atypical antipsychotic, indicated......click on news to read complete article.

International Stock News
US markets closed higher on Monday
(12-Dec-2017)

US markets closed higher on MondayThe US markets closed higher on Monday, with the S&P 500 index and Dow industrials closing at records on the back of a rally in telecommunications and technology shares. Wall Street shrugged off......click on news to read complete article.

Asian markets trade higher in early deals on Monday
(11-Dec-2017)

Asian markets trade higher in early deals on MondayAsian equity benchmark indices are trading higher in the early deals on Monday, lifted by encouraging employment data from the US that took the Standard & Poor's 500 Index to its third straight......click on news to read complete article.

US markets end at record highs on upbeat jobs data
(09-Dec-2017)

US markets end at record highs on upbeat jobs dataThe US markets traded with traction and ended near record high levels on Friday, as traders reacted positively to the closely watched monthly jobs report. The continued advance by stocks came following......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.